Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

AKT Inhibition Modulates H3K4 Demethylase Levels in PTEN-Null Prostate Cancer.

Khan MI, Hamid A, Rath S, Ateeq B, Khan Q, Siddiqui IA, Adhami VM, Choudhry H, Zamzami MA, Mukhtar H.

Mol Cancer Ther. 2019 Feb;18(2):356-363. doi: 10.1158/1535-7163.MCT-18-0141. Epub 2018 Nov 16.

PMID:
30446585
2.

Proproliferative function of adaptor protein GRB10 in prostate carcinoma.

Khan MI, Al Johani A, Hamid A, Ateeq B, Manzar N, Adhami VM, Lall RK, Rath S, Sechi M, Siddiqui IA, Choudhry H, Zamzami MA, Havighurst TC, Huang W, Ntambi JM, Mukhtar H.

FASEB J. 2019 Mar;33(3):3198-3211. doi: 10.1096/fj.201800265RR. Epub 2018 Oct 31.

PMID:
30379590
3.

Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.

Chamcheu JC, Siddiqui IA, Adhami VM, Esnault S, Bharali DJ, Babatunde AS, Adame S, Massey RJ, Wood GS, Longley BJ, Mousa SA, Mukhtar H.

Int J Nanomedicine. 2018 Jul 20;13:4189-4206. doi: 10.2147/IJN.S165966. eCollection 2018.

4.

cRGD functionalised nanocarriers for targeted delivery of bioactives.

Gajbhiye KR, Gajbhiye V, Siddiqui IA, Gajbhiye JM.

J Drug Target. 2018 May 23:1-14. doi: 10.1080/1061186X.2018.1473409. [Epub ahead of print]

PMID:
29737883
5.

Fellows' perspective of HPB training programs in North America: results of a survey.

Siddiqui IA, Sastry AV, Martinie JB, Vrochides D, Baker EH, Iannitti DA.

HPB (Oxford). 2018 Aug;20(8):695-701. doi: 10.1016/j.hpb.2018.01.012. Epub 2018 Mar 8.

PMID:
29525118
6.

Neutrophil-to-lymphocyte ratio and microvascular complications in subjects with type 2 diabetes: Pakistan’s perspective

Fawwad A, Butt AM, Siddiqui IA, Khalid M, Sabir R, Basit A.

Turk J Med Sci. 2018 Feb 23;48(1):157-161. doi: 10.3906/sag-1706-141.

PMID:
29479977
7.

Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: An in vitro-in vivo study.

Gajbhiye KR, Gajbhiye V, Siddiqui IA, Pilla S, Soni V.

Sci Rep. 2017 Sep 11;7(1):11086. doi: 10.1038/s41598-017-11611-4.

8.

Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy.

Rady I, Siddiqui IA, Rady M, Mukhtar H.

Cancer Lett. 2017 Aug 28;402:16-31. doi: 10.1016/j.canlet.2017.05.010. Epub 2017 May 20. Review.

9.

High-Frequency Irreversible Electroporation: Safety and Efficacy of Next-Generation Irreversible Electroporation Adjacent to Critical Hepatic Structures.

Siddiqui IA, Kirks RC, Latouche EL, DeWitt MR, Swet JH, Baker EH, Vrochides D, Iannitti DA, Davalos RV, McKillop IH.

Surg Innov. 2017 Jun;24(3):276-283. doi: 10.1177/1553350617692202. Epub 2017 Feb 1.

PMID:
28492356
10.

Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.

Sanna V, Singh CK, Jashari R, Adhami VM, Chamcheu JC, Rady I, Sechi M, Mukhtar H, Siddiqui IA.

Sci Rep. 2017 Feb 1;7:41573. doi: 10.1038/srep41573.

11.
12.

Analysis of Zinc-Exporters Expression in Prostate Cancer.

Singh CK, Malas KM, Tydrick C, Siddiqui IA, Iczkowski KA, Ahmad N.

Sci Rep. 2016 Nov 11;6:36772. doi: 10.1038/srep36772.

13.

Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells.

Mukhtar E, Adhami VM, Siddiqui IA, Verma AK, Mukhtar H.

Mol Cancer Ther. 2016 Dec;15(12):2863-2874. Epub 2016 Oct 7.

14.

Clinical Cold Welding of the Modular Total Hip Arthroplasty Prosthesis.

Whittaker RK, Zaghloul AM, Hothi HS, Siddiqui IA, Blunn GW, Skinner JA, Hart AJ.

J Arthroplasty. 2017 Feb;32(2):610-615. doi: 10.1016/j.arth.2016.07.020. Epub 2016 Aug 10.

PMID:
27665242
15.

Induction of rapid, reproducible hepatic ablations using next-generation, high frequency irreversible electroporation (H-FIRE) in vivo.

Siddiqui IA, Latouche EL, DeWitt MR, Swet JH, Kirks RC, Baker EH, Iannitti DA, Vrochides D, Davalos RV, McKillop IH.

HPB (Oxford). 2016 Sep;18(9):726-34. doi: 10.1016/j.hpb.2016.06.015. Epub 2016 Jul 26.

16.

Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.

Chamcheu JC, Adhami VM, Esnault S, Sechi M, Siddiqui IA, Satyshur KA, Syed DN, Dodwad SM, Chaves-Rodriquez MI, Longley BJ, Wood GS, Mukhtar H.

Antioxid Redox Signal. 2017 Jan 10;26(2):49-69. doi: 10.1089/ars.2016.6769. Epub 2016 Oct 4.

17.

Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy.

Siddiqui IA, Sanna V.

Mol Nutr Food Res. 2016 Jun;60(6):1330-41. doi: 10.1002/mnfr.201600035. Epub 2016 Apr 4. Review.

PMID:
26935239
18.

Upregulation of PI3K/AKT/mTOR, FABP5 and PPARβ/δ in Human Psoriasis and Imiquimod-induced Murine Psoriasiform Dermatitis Model.

Chamcheu JC, Chaves-Rodriquez MI, Adhami VM, Siddiqui IA, Wood GS, Longley BJ, Mukhtar H.

Acta Derm Venereol. 2016 Aug 23;96(6):854-6. doi: 10.2340/00015555-2359. No abstract available.

19.

Combination chemoprevention with grape antioxidants.

Singh CK, Siddiqui IA, El-Abd S, Mukhtar H, Ahmad N.

Mol Nutr Food Res. 2016 Jun;60(6):1406-15. doi: 10.1002/mnfr.201500945. Epub 2016 Mar 3. Review.

20.

Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment.

Sanna V, Chamcheu JC, Pala N, Mukhtar H, Sechi M, Siddiqui IA.

Int J Nanomedicine. 2015 Oct 30;10:6835-46. doi: 10.2147/IJN.S93752. eCollection 2015.

21.

Chemical chaperone therapy, a new strategy for genetic skin fragility disorders.

Chamcheu JC, Siddiqui IA, Mukhtar H.

Exp Dermatol. 2016 Mar;25(3):183-4. doi: 10.1111/exd.12893. No abstract available.

22.

Differences in various biochemical and clinical parameters with respect to family history of Non Communicable Diseases in fourth year MBBS students of Karachi, Pakistan.

Basit KA, Fawwad A, Munir MA, Siddiqui IA, Siddiqui S, Basit A.

Pak J Med Sci. 2015 Jul-Aug;31(4):965-9. doi: 10.12669/pjms.314.7021.

23.

Resveratrol nanoformulation for cancer prevention and therapy.

Siddiqui IA, Sanna V, Ahmad N, Sechi M, Mukhtar H.

Ann N Y Acad Sci. 2015 Aug;1348(1):20-31. doi: 10.1111/nyas.12811. Epub 2015 Jun 24. Review.

PMID:
26109073
24.

Consequences of traffic noise in residents of Karachi, Pakistan.

Siddiqui IA, Nizami S, Chandio RR, Nizami S, Sikander N, Ashraf S.

Pak J Med Sci. 2015 Mar-Apr;31(2):448-52. doi: 10.12669/pjms.312.6367.

25.

Association of SNP rs9939609 in FTO gene with metabolic syndrome in type 2 diabetic subjects, rectruited from a tertiary care unit of Karachi, Pakistan.

Fawwad A, Siddiqui IA, Zeeshan NF, Shahid SM, Basit A.

Pak J Med Sci. 2015 Jan-Feb;31(1):140-5. doi: 10.12669/pjms.311.6524.

26.

A learning skills course for the 1st year medical students: an experience at a Saudi medical school.

Siddiqui IA, Bin Abdulrahman KA, Alsultan MA.

Adv Med Educ Pract. 2015 Mar 23;6:205-10. doi: 10.2147/AMEP.S77717. eCollection 2015.

27.

Common variant within the FTO gene, rs9939609, obesity and type 2 diabetes in population of Karachi, Pakistan.

Fawwad A, Siddiqui IA, Basit A, Zeeshan NF, Shahid SM, Nawab SN, Siddiqui S.

Diabetes Metab Syndr. 2016 Jan-Mar;10(1):43-7. doi: 10.1016/j.dsx.2015.02.001. Epub 2015 Feb 24.

PMID:
25757373
28.

Prodifferentiation, anti-inflammatory and antiproliferative effects of delphinidin, a dietary anthocyanidin, in a full-thickness three-dimensional reconstituted human skin model of psoriasis.

Chamcheu JC, Pal HC, Siddiqui IA, Adhami VM, Ayehunie S, Boylan BT, Noubissi FK, Khan N, Syed DN, Elmets CA, Wood GS, Afaq F, Mukhtar H.

Skin Pharmacol Physiol. 2015;28(4):177-88. doi: 10.1159/000368445. Epub 2015 Jan 22.

29.

Maternal Serum Lipids in Women with Pre-eclampsia.

Siddiqui Ia.

Ann Med Health Sci Res. 2014 Jul;4(4):638-41. doi: 10.4103/2141-9248.139358.

30.

Methaneseleninic acid and γ-Tocopherol combination inhibits prostate tumor growth in Vivo in a xenograft mouse model.

Singh CK, Ndiaye MA, Siddiqui IA, Nihal M, Havighurst T, Kim K, Zhong W, Mukhtar H, Ahmad N.

Oncotarget. 2014 Jun 15;5(11):3651-61.

31.

Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo.

Siddiqui IA, Bharali DJ, Nihal M, Adhami VM, Khan N, Chamcheu JC, Khan MI, Shabana S, Mousa SA, Mukhtar H.

Nanomedicine. 2014 Nov;10(8):1619-26. doi: 10.1016/j.nano.2014.05.007. Epub 2014 Jun 3.

PMID:
24965756
32.

YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule fisetin.

Khan MI, Adhami VM, Lall RK, Sechi M, Joshi DC, Haidar OM, Syed DN, Siddiqui IA, Chiu SY, Mukhtar H.

Oncotarget. 2014 May 15;5(9):2462-74.

33.

A comparison of the diagnostic accuracy of MARS MRI and ultrasound of the painful metal-on-metal hip arthroplasty.

Siddiqui IA, Sabah SA, Satchithananda K, Lim AK, Cro S, Henckel J, Skinner JA, Hart AJ.

Acta Orthop. 2014 Aug;85(4):375-82. doi: 10.3109/17453674.2014.908345. Epub 2014 Apr 3.

34.

Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma.

Malik UU, Siddiqui IA, Hashim Z, Zarina S.

Clin Chim Acta. 2014 Mar 20;430:38-42. doi: 10.1016/j.cca.2013.12.033. Epub 2014 Jan 2.

PMID:
24389054
35.

Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.

Khan N, Bharali DJ, Adhami VM, Siddiqui IA, Cui H, Shabana SM, Mousa SA, Mukhtar H.

Carcinogenesis. 2014 Feb;35(2):415-23. doi: 10.1093/carcin/bgt321. Epub 2013 Sep 26.

36.

The S100A4 Oncoprotein Promotes Prostate Tumorigenesis in a Transgenic Mouse Model: Regulating NFκB through the RAGE Receptor.

Siddique HR, Adhami VM, Parray A, Johnson JJ, Siddiqui IA, Shekhani MT, Murtaza I, Ambartsumian N, Konety BR, Mukhtar H, Saleem M.

Genes Cancer. 2013 May;4(5-6):224-34. doi: 10.1177/1947601913492420.

37.

Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment.

Sanna V, Siddiqui IA, Sechi M, Mukhtar H.

Mol Pharm. 2013 Oct 7;10(10):3871-81. doi: 10.1021/mp400342f. Epub 2013 Sep 4.

38.

[MRI investigations in patients with problems due to metal-on-metal implants].

Parsons TM, Satchithananda K, Berbe R, Siddiqui IA, Robinson E, Hart AJ.

Orthopade. 2013 Aug;42(8):629-36. doi: 10.1007/s00132-012-2036-2. German. Erratum in: Orthopade. 2014 Jan;43(1):91. Parsons, T M [added]; Satchithananda, K [added]; Berbe, R [added]; Siddiqui, I A [added]; Robinson, E [added]; Hart, A [corrected to Hart, A J].

PMID:
23912305
39.
40.

The dietary terpene lupeol targets colorectal cancer cells with constitutively active Wnt/β-catenin signaling.

Tarapore RS, Siddiqui IA, Adhami VM, Spiegelman VS, Mukhtar H.

Mol Nutr Food Res. 2013 Nov;57(11):1950-8. doi: 10.1002/mnfr.201300155. Epub 2013 Jul 9.

41.

Cross-sectional imaging of the metal-on-metal hip prosthesis: the London ultrasound protocol.

Siddiqui IA, Sabah SA, Satchithananda K, Lim AK, Henckel J, Skinner JA, Hart AJ.

Clin Radiol. 2013 Aug;68(8):e472-8. doi: 10.1016/j.crad.2013.02.003. Epub 2013 May 17. No abstract available.

42.

Delphinidin, a dietary antioxidant, induces human epidermal keratinocyte differentiation but not apoptosis: studies in submerged and three-dimensional epidermal equivalent models.

Chamcheu JC, Afaq F, Syed DN, Siddiqui IA, Adhami VM, Khan N, Singh S, Boylan BT, Wood GS, Mukhtar H.

Exp Dermatol. 2013 May;22(5):342-8. doi: 10.1111/exd.12140.

43.

Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer.

Xu W, Siddiqui IA, Nihal M, Pilla S, Rosenthal K, Mukhtar H, Gong S.

Biomaterials. 2013 Jul;34(21):5244-53. doi: 10.1016/j.biomaterials.2013.03.006. Epub 2013 Apr 11.

44.

Biomarkers of oxidative stress in women with pre-eclampsia.

Siddiqui IA, Jaleel A, Al'Kadri HM, Akram S, Tamimi W.

Biomark Med. 2013 Apr;7(2):229-34. doi: 10.2217/bmm.12.109.

PMID:
23547818
45.

Nanoformulation of natural products for prevention and therapy of prostate cancer.

Sanna V, Siddiqui IA, Sechi M, Mukhtar H.

Cancer Lett. 2013 Jun 28;334(1):142-51. doi: 10.1016/j.canlet.2012.11.037. Epub 2012 Nov 29. Review.

46.

MAGE-C2 promotes growth and tumorigenicity of melanoma cells, phosphorylation of KAP1, and DNA damage repair.

Bhatia N, Xiao TZ, Rosenthal KA, Siddiqui IA, Thiyagarajan S, Smart B, Meng Q, Zuleger CL, Mukhtar H, Kenney SC, Albertini MR, Jack Longley B.

J Invest Dermatol. 2013 Mar;133(3):759-767. doi: 10.1038/jid.2012.355. Epub 2012 Oct 25.

47.

Age and BMI Adjusted Comparison of Reproductive Hormones in PCOS.

Fakhoury H, Tamim H, Ferwana M, Siddiqui IA, Adham M, Tamimi W.

J Family Med Prim Care. 2012 Jul;1(2):132-6. doi: 10.4103/2249-4863.104984.

48.

Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise.

Chamcheu JC, Wood GS, Siddiqui IA, Syed DN, Adhami VM, Teng JM, Mukhtar H.

Exp Dermatol. 2012 Jul;21(7):481-9. doi: 10.1111/j.1600-0625.2012.01534.x. Review.

49.

Faculty development program: a guide for medical schools in Arabian Gulf (GCC) countries.

Bin Abdulrahman KA, Siddiqui IA, Aldaham SA, Akram S.

Med Teach. 2012;34 Suppl 1:S61-6. doi: 10.3109/0142159X.2012.656748. Review.

PMID:
22409194
50.

Impact of nanotechnology in cancer: emphasis on nanochemoprevention.

Siddiqui IA, Adhami VM, Chamcheu JC, Mukhtar H.

Int J Nanomedicine. 2012;7:591-605. doi: 10.2147/IJN.S26026. Epub 2012 Feb 2. Review.

Supplemental Content

Loading ...
Support Center